Czuczman Myron 4
4 · Citius Pharmaceuticals, Inc. · Filed Oct 13, 2021
Insider Transaction Report
Form 4
Czuczman Myron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Purchase Common Stock)
2021-10-11+300,000→ 300,000 totalExercise: $2.04Exp: 2031-10-11→ Common Stock (300,000 underlying)
Holdings
- 500,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.19Exp: 2030-07-14→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F2]One-third of the shares of the Company's common stock underlying the grant vest on the one-year anniversary of the Vesting Commencement Date, July 14, 2020, with the remainder vesting in 24 equal monthly installments thereafter, provided that the Optionee provides Continuous Service to the Company on each such vesting date.